Page 82 - Buku Referensi Biopolimer Kitosan

DAFTAR PUSTAKA

A i i, S. 2015. Solid dispersion approach improving dissolution rate
of stiripentol: a novel antiepileptic drug. Irian Journal of
Pharmaceutical Research. 14(4), 1001-1014.

Aiba, S. 1992. Studies on chitosan: 4. Lysozimic hydrolysis of partially
N-acetylated chitosans. Int. J. Biol. Macromol. 14: 225-228.
Allam, A.N., Naggar, V.F., El Gamal, S.S. 2013. Formulation and
Physicochemical Characterization of Chitosan/Acyclovir
Co-crystals. Pharmaceutical Development and Technology.

18(4), 856-65
Amidon, G.L., Lennern ̈as, H., Shah, V.P., and Crison, J.R. 1995.
Atheoretical basis for a biopharmaceutic drug classi ication:

thecorrelation of in vitro drug product dissolution and in
vivobioavailability. Pharmaceutical Research, 12(3), 413–
420.
Amorim, R.V., Melo ES, Carneiro-da-Cunha MG, Ledingham WM, and
Campos-Takaki GM. 2003. Chitosan from Syncephalastrum
racemosum used as a ilm support for lipase immobilization.
Bioresour. Technol. 89: 35–39.

Aranaz, I., Mengibar M, Harris R, Panos I, Miralles B, and Acosta N.
2009. Functional characterization of chitin and chitosan.

Curr Chem Biol. 3: 203–230.
Badwan, A.A., El Khordagui, L.K., Saleh, A.M., and Khalil, S.A. 1983. The
solubility of benzodiazepines in sodium salicylate solution
and a proposed mechanism for hydrotropic solubi-lization.
International Journal of Pharmaceutics. 13(1), 67–74.

74 BIOPOLIMER KITOSAN DAN PENGGUNAANNYA ALAM FORMULASI OBAT